Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections.

Saved in:
Bibliographic Details
Title: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections.
Authors: Howard-Anderson J; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Hamasaki T; The Biostatistics Center and Department of Biostatics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington, D.C., USA., Ge L; The Biostatistics Center and Department of Biostatics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington, D.C., USA., Collyar D; Patient Advocates in Research, Danville, California, USA., Cosgrove SE; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Doernberg SB; Division of Infectious Diseases, Department of Medicine, University of California School of Medicine, SanFrancisco, California, USA., Geres H; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA., Gopinath R; Center for Drug Evaluation and Research, United States Food and Drug Administration, Washington, D.C., USA., Holland TL; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., King HA; Division of Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.; Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Health Care System, Durham, North Carolina, USA., Nambiar S; Johnson & Johnson, Raritan, New Jersey, USA., Rubin D; Center for Drug Evaluation and Research, United States Food and Drug Administration, Washington, D.C., USA., Chambers HF; Division of Infectious Diseases, Department of Medicine, University of California School of Medicine, SanFrancisco, California, USA., Fowler VG; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Evans SR; The Biostatistics Center and Department of Biostatics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington, D.C., USA., Boucher HW; Tufts University School of Medicine and Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA.
Source: Open forum infectious diseases [Open Forum Infect Dis] 2026 Jun 22; Vol. 13 (6), pp. ofag320. Date of Electronic Publication: 2026 Jun 22 (Print Publication: 2026).
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42339770
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Howard-Anderson+J%22">Howard-Anderson J</searchLink>; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Hamasaki+T%22">Hamasaki T</searchLink>; The Biostatistics Center and Department of Biostatics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington, D.C., USA.<br /><searchLink fieldCode="AU" term="%22Ge+L%22">Ge L</searchLink>; The Biostatistics Center and Department of Biostatics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington, D.C., USA.<br /><searchLink fieldCode="AU" term="%22Collyar+D%22">Collyar D</searchLink>; Patient Advocates in Research, Danville, California, USA.<br /><searchLink fieldCode="AU" term="%22Cosgrove+SE%22">Cosgrove SE</searchLink>; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Doernberg+SB%22">Doernberg SB</searchLink>; Division of Infectious Diseases, Department of Medicine, University of California School of Medicine, SanFrancisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Geres+H%22">Geres H</searchLink>; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Gopinath+R%22">Gopinath R</searchLink>; Center for Drug Evaluation and Research, United States Food and Drug Administration, Washington, D.C., USA.<br /><searchLink fieldCode="AU" term="%22Holland+TL%22">Holland TL</searchLink>; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22King+HA%22">King HA</searchLink>; Division of Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA.; Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Health Care System, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Nambiar+S%22">Nambiar S</searchLink>; Johnson & Johnson, Raritan, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Rubin+D%22">Rubin D</searchLink>; Center for Drug Evaluation and Research, United States Food and Drug Administration, Washington, D.C., USA.<br /><searchLink fieldCode="AU" term="%22Chambers+HF%22">Chambers HF</searchLink>; Division of Infectious Diseases, Department of Medicine, University of California School of Medicine, SanFrancisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Fowler+VG%22">Fowler VG</searchLink>; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Evans+SR%22">Evans SR</searchLink>; The Biostatistics Center and Department of Biostatics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington, D.C., USA.<br /><searchLink fieldCode="AU" term="%22Boucher+HW%22">Boucher HW</searchLink>; Tufts University School of Medicine and Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101637045%22">Open forum infectious diseases</searchLink> [Open Forum Infect Dis] 2026 Jun 22; Vol. 13 (6), pp. ofag320. <i>Date of Electronic Publication: </i>2026 Jun 22 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Published+by+Oxford+University+Press+on+behalf+of+the+Infectious+Diseases+Society+of+America%22">Published by Oxford University Press on behalf of the Infectious Diseases Society of America </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101637045 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2328-8957 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223288957%22">23288957 </searchLink><i>NLM ISO Abbreviation: </i>Open Forum Infect Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42339770
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/ofid/ofag320
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: ofag320
    Titles:
      – TitleFull: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Howard-Anderson J
      – PersonEntity:
          Name:
            NameFull: Hamasaki T
      – PersonEntity:
          Name:
            NameFull: Ge L
      – PersonEntity:
          Name:
            NameFull: Collyar D
      – PersonEntity:
          Name:
            NameFull: Cosgrove SE
      – PersonEntity:
          Name:
            NameFull: Doernberg SB
      – PersonEntity:
          Name:
            NameFull: Geres H
      – PersonEntity:
          Name:
            NameFull: Gopinath R
      – PersonEntity:
          Name:
            NameFull: Holland TL
      – PersonEntity:
          Name:
            NameFull: King HA
      – PersonEntity:
          Name:
            NameFull: Nambiar S
      – PersonEntity:
          Name:
            NameFull: Rubin D
      – PersonEntity:
          Name:
            NameFull: Chambers HF
      – PersonEntity:
          Name:
            NameFull: Fowler VG
      – PersonEntity:
          Name:
            NameFull: Evans SR
      – PersonEntity:
          Name:
            NameFull: Boucher HW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 06
              Text: 2026 Jun 22
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2328-8957
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Open forum infectious diseases
              Type: main
ResultId 1